Overall, our data suggest that deregulated Akt1/mTOR signaling in ERMS cells, promoting an aggressive tumor phenotype, can become the Achilles’ heel for the tumor if the availability of some nutrients or their metabolism is disrupted. This evidence concerns the gene MTOR and neoplasm.